Table 1.

Clinical characteristics

VariableCategoryDistribution
Age, yMedian (range)71 (55–83)
cT-categorya,T1104 (42)
n (%)T2142 (57)
T31 (<1)
Gleason671 (29)
score, n (%)7163 (66)
8, 913 (5)
PSA, n (%)Median (range)7.8 (0.9–33) ng/mL
≤10 ng/mL164 (66%)
10.1–20 ng/mL76 (31%)
>20 ng/mL7 (3%)
Proportion-positive biopsiesbMedian (range)0.43 (0–1.0)
HormonalYes52 (21)
treatmentc, n (%)No195 (79)
Radiotherapy70 Gyd1 (<1)
dose, n (%)75.6 Gyd71 (29)
78–79.8 Gyd148 (60)
60–66 Gye27 (11)
  • aUICC-TNM classification, 6th edition, 2002.

  • bThe proportion of diagnostic biopsy cores that contained cancer.

  • cNeoadjuvant and concurrent hormonal treatment.

  • d1.8 to 2 Gy per fraction.

  • e3 Gy per fraction.